SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
WithumSmith+Brown, PC was dismissed as Live Oak's independent registered public accounting firm on June 18, 2026, and KPMG was concurrently appointed as the new auditor in connection with the reverse recapitalization transaction.
View raw filing on EDGAR →The combined company approved and implemented three equity incentive plans: the 2026 Incentive Award Plan (5,039,004 shares, 7% of post-Closing shares), the 2026 Employee Stock Purchase Plan (1,439,715 shares, 2% of post-Closing shares), and assumed the 2020 Equity Incentive Plan, all designed to attract and retain key personnel and approved by shareholders on June 16, 2026.
View raw filing on EDGAR →Apollo Infrastructure Company LLC issued and sold approximately $35.5 million in unregistered equity securities across multiple share classes (Series I and Series II A-II, F-I, and I Shares) to third-party investors as of June 1, 2026, under Section 4(a)(2) and Regulations D and S exemptions.
View raw filing on EDGAR →This Item 5.07 disclosure presents the final voting results from the Company's 2026 Annual Meeting of Stockholders, including the election of three directors (H. Michael Schwartz, Brent Chappell, and Stephen G. Muzzy) and ratification of BDO USA, P.C. as the independent auditor. The filing directly matches the shareholder_vote_results event type, which covers results of votes at annual or special meetings of security holders.
View raw filing on EDGAR →Apollo Asset Backed Credit Company LLC completed unregistered sales of equity securities totaling approximately $49.1 million across Series I and Series II share classes to third-party investors as of June 1, 2026, exempt from Securities Act registration under Section 4(a)(2), Regulation D, and/or Regulation S. The issuance of over 1.9 million shares across multiple series represents material capital raising activity that dilutes existing shareholders.
View raw filing on EDGAR →Apollo Asset Backed Credit Co LLC declared distributions on multiple share classes with per-share amounts ranging from $0.0835 to $0.1596, payable on July 28, 2026. The distribution declaration represents a material capital return to shareholders across Series I and Series II shares.
View raw filing on EDGAR →This is a Cooperation and Development Agreement between Party A (Pet Sunshine Biological Research Co., Ltd., a Taiwan-registered entity) and Party B (Cordyceps Sunshine Biotech Holdings Co., Ltd., the Cayman Islands-registered filer). Party A grants Party B exclusive, irrevocable, worldwide rights to develop, commercialize, license, and manage the Antcin A platform (a next-generation non-steroidal anti-inflammatory drug platform) on a royalty-free basis, with 50/50 revenue sharing and preemptive/call options on future transactions. This constitutes a material strategic transaction involving transfer of exclusive commercialization and capital-markets development rights, even though legal ownership remains with Party A. The agreement explicitly contemplates future integration, M&A, and restructuring, and grants Party B substantial control over a core asset platform.
View raw filing on EDGAR →MoonLake entered into an underwriting agreement on June 23, 2026 to conduct a public offering of 9,000,000 Class A ordinary shares at $20.00 per share, plus pre-funded warrants and an option for underwriters to purchase an additional 1,500,000 shares. The offering is expected to generate approximately $200 million in gross proceeds. This is a material dilutive equity issuance that would significantly affect shareholder ownership percentages and is disclosed under Item 1.01 as a material definitive agreement.
View raw filing on EDGAR →This press release announces a significant clinical development milestone: the last patient has been successfully dosed in the Phase 2a INFORM-MS trial of intranasal foralumab for non-active secondary progressive multiple sclerosis, with topline data expected in late Q3/early Q4 2026. This is a material operational/clinical milestone for a clinical-stage biopharmaceutical company whose lead candidate is the subject of the trial, as it represents progress toward potential regulatory approval and commercialization of its primary therapeutic asset. The disclosure does not fit the specific event types (e.g., it is not an earnings release, M&A activity, or executive change), but is clearly material to investors assessing the company's pipeline advancement and clinical execution.
View raw filing on EDGAR →The filing discloses a U.S. patent grant for IHL-42X in obstructive sleep apnoea with an expiry date of July 9, 2040, plus potential patent term extension eligibility. This is a material intellectual property milestone for a clinical-stage biopharmaceutical company's lead program, strengthening its competitive position and long-term exclusivity. While not fitting a specific named event type, this is clearly an operational/strategic business event—a regulatory/IP milestone—that would affect a reasonable investor's assessment of the company's asset value and development trajectory.
View raw filing on EDGAR →This is a press release dated June 25, 2026 announcing Nano-X Imaging's first quarter 2026 financial results. The exhibit discloses detailed quarterly financial metrics including revenue ($4.3M vs. $2.8M YoY), gross loss, operating expenses, and net loss ($14.3M), along with management commentary on business performance and outlook. The disclosure includes a material going-concern warning and withdrawal of 2026 revenue guidance, making this a substantive earnings announcement that would materially affect investor assessment.
View raw filing on EDGAR →The disclosure announces the death of E. Forrest Jones, Jr., who served as the Company's General Counsel (since May 2025) and as a former Board member and Director Emeritus (since March 2025). This constitutes an executive departure due to death. While the Item 7.01 classification and the "Regulation FD Disclosure" framing suggest routine disclosure, the substance is a material loss of a named executive officer and former director whose role in governance and legal affairs was significant to the organization.
View raw filing on EDGAR →Launch Two Acquisition Corp. (a SPAC) entered into a definitive Business Combination Agreement with NuCube Energy, Inc., an advanced-nuclear technology company, dated June 25, 2026. The transaction values NuCube at approximately $500 million pre-money equity value, is expected to generate up to $125 million in gross proceeds, and will result in NuCube becoming a publicly listed company with expected closing in the second half of 2026, subject to shareholder approval and regulatory conditions.
View raw filing on EDGAR →Mint Incorporation Ltd entered into a joint venture agreement with YAS Digital Group Ltd to establish YAS Robotics Limited, a new Hong Kong-based company focused on robotics and AI insurance products, with Mint holding 25% of the JV Company's issued shares.
View raw filing on EDGAR →Mint's wholly-owned subsidiary Axonex announced a strategic collaboration with YAS to develop embedded micro-insurance solutions for commercial robots, with underwriting from a global Swiss-headquartered insurance group, expanding Mint's business model from hardware-only to hardware, data, and insurance offerings.
View raw filing on EDGAR →Triller Group entered into a definitive membership interest purchase agreement on June 23, 2026, to acquire 100% of the Holdings Membership Interests for $411.3 million, providing economic exposure to 3.9 million SpaceX shares. The company characterized this as a transformational acquisition that will be held as a strategic treasury asset and fundamentally changes its capital structure and investor positioning.
View raw filing on EDGAR →This Item 1.01 discloses Amendment No. 2 to the Agreement and Plan of Merger between Bleichroeder Acquisition Corp. II (Parent), its merger subsidiary, and Pasqal Holding SAS. The amendment modifies material terms of the business combination agreement, specifically the composition of the surviving corporation's board of directors and the equity incentive plan terms. This constitutes an entry into a material definitive agreement amendment related to a merger transaction, which is the core M&A activity event type.
View raw filing on EDGAR →IceCure announced on June 25, 2026, that it has regained compliance with Nasdaq's minimum bid price requirement (Listing Rule 5550(a)(2)) after the closing bid price reached $1.00 or greater for 10 consecutive business days. This disclosure directly addresses a delisting risk — the company had previously fallen below the $1.00 minimum bid price threshold and faced potential delisting, but has now cured that deficiency. The announcement explicitly states "Nasdaq considers the bid price deficiency matter now closed," confirming resolution of a material listing compliance issue.
View raw filing on EDGAR →This press release announces positive biomarker findings from a Phase 2 proof-of-concept clinical trial (RoAD study) of PrimeC in Alzheimer's disease. The disclosure reports early biological evidence of target engagement across multiple neurodegenerative disease pathways and supports continued development of the drug candidate. While this is a clinical/operational milestone rather than a discrete financial event, earnings release, or governance matter, it represents a material development in the company's drug pipeline that would affect a reasonable investor's assessment of NeuroSense's prospects and strategy in neurodegenerative disease treatment.
View raw filing on EDGAR →The filing discloses a proposed merger of ENDRA's subsidiary with Noble Africa LLC (a wholly-owned subsidiary of ASP Isotopes), with Noble Africa as the surviving entity. The transaction is expected to close in Q3 or Q4 2026 and includes a concurrent $50 million private placement financing. This is a material acquisition/change of control event that would substantially affect ENDRA's stockholders, who are expected to own approximately 3% of the combined company post-closing, with ASP Isotopes owning ~89%.
View raw filing on EDGAR →This press release announces a material shift in the Company's principal business activities and strategic direction. ATGL is formally disclosing that its core focus is now "Exclusive Large Language Model (Exclusive LLM) solutions" and introducing two integrated offerings: AlphaClaw AI Agents and the AlphaClaw AI Agent Marketplace. The filing explicitly states that "The Company's previous cloud-based IT solutions and AI OCR services have been integrated into or replaced by Exclusive LLM and AlphaClaw offerings, which now form the core of its revenue-generating operations." This represents a significant operational and strategic repositioning that would materially affect a reasonable investor's assessment of the Company's business model and growth prospects, though it does not fit neatly into the specific event categories (not M&A, not a financial result, not a governance change, not a restructuring charge). It is best classified as an operational/strategic business event.
View raw filing on EDGAR →Zoomcar announced an extension of its warrant-for-common-stock exchange offer, which involves converting outstanding warrants into shares of common stock. This is a dilutive capital transaction that increases the share count and requires stockholder approval to increase authorized shares. While the core event is a warrant exchange rather than a new issuance, the economic effect—dilution of existing shareholders through warrant conversion—aligns with dilutive_issuance. The extension itself is administrative, but the underlying offer materially affects capital structure.
View raw filing on EDGAR →The exhibit is a Material Change Report (Form 51-102F3) announcing the appointment of Richard Pozzebon as Chief Financial Officer of Titan Mining Corporation, effective July 6, 2026. The appointment of a named executive officer to a C-suite position is a material governance event that would affect a reasonable investor's assessment of the company's leadership and financial oversight.
View raw filing on EDGAR →The Compensation Committee approved material changes to CEO Brent Lucas's compensation package, including an updated base salary of $420,000, a targeted cash bonus of $105,000, and equity grants of 1,000,000 stock options and 1,000,000 RSUs with performance-based vesting tied to FDA approval of the Acclaim cochlear implant. This is a compensatory arrangement disclosure under Item 5.02(e), distinct from an appointment or departure.
View raw filing on EDGAR →The 6-K discloses results of the Company's Annual General Meeting of Shareholders held on June 23, 2026, at which shareholders approved six proposals including re-election of directors (David Milch and Ruth Alon), re-approval of the compensation policy, re-appointment of Uzi Sofer as Chairman, approval of his compensation package, extension of option terms, and re-appointment of the independent auditor. This is a classic shareholder vote results disclosure under Item 5.07 equivalent, and the approval of executive compensation and auditor re-appointment are material governance matters.
View raw filing on EDGAR →This press release announces the results of Mega Matrix Inc.'s 2026 Annual General Meeting held on June 22, 2026. Shareholders approved four discrete proposals: (1) election of four board directors, (2) a 20-for-1 share consolidation, (3) amended memorandum and articles of association, and (4) appointment of Audit Alliance LLP as independent auditor. The disclosure of shareholder vote outcomes on these material governance and capital structure matters is a classic shareholder_vote_results event, material to investors assessing the company's governance and capitalization.
View raw filing on EDGAR →The Company consummated its initial public offering of 25,000,000 Class A ordinary shares at $10.00 per share, generating $250,000,000 in gross proceeds, simultaneously with a private placement of 600,000 Class A ordinary shares to the Sponsor for $6,000,000. This is a material capital-raising event involving the issuance of equity securities to the public and a sponsor, typical of a special purpose acquisition company (SPAC) IPO structure. While the filing emphasizes the trust account mechanism and business combination intent rather than immediate dilution to existing shareholders (as this is an IPO with no prior public shareholders), the event represents a substantial dilutive issuance of equity that would materially affect a reasonable investor's assessment of the registrant's capital structure and future ownership.
View raw filing on EDGAR →This Item 8.01 disclosure supplements a definitive proxy statement for a pending business combination by announcing the addition of two independent director nominees (William Koschak and Jonathan Bond) to the combined entity's board following the Business Combination. While the section also includes business development updates regarding product shipments and hospital projects, the primary governance action is the appointment of these directors and their committee assignments. This is a material governance event affecting the post-combination board composition, though it is technically supplemental disclosure to an already-filed proxy rather than a standalone appointment announcement.
View raw filing on EDGAR →The 6-K discloses the closing of a disposition (sale) of a wholly-owned subsidiary, Guangdong Tiancheng Jinhui Enterprise Development Group Co., Ltd., to an unaffiliated purchaser for US$218,100 cash consideration on June 18, 2026. This is a material acquisition/disposition event under Item 1.02 (Completion of Acquisition or Disposition of Assets) or Item 2.01 (Completion of Acquisition or Disposition of Assets), representing a change in the company's asset base and organizational structure.
View raw filing on EDGAR →Gaxos.ai Inc. completed the sale of substantially all of its gaming assets, including its mobile games portfolio and Gaxos Gaming Lab, to Game Foundry AI on June 18, 2026, in exchange for 2,200,000 shares valued at approximately $1.76 million. The transaction resulted in a gain of $1.74 million and represents a strategic shift to concentrate resources on the company's revenue-generating AI business lines.
View raw filing on EDGAR →Flash Sports & Media announced the planned launch of the Zimbabwe T20 League (ZT20), a new professional franchise cricket league scheduled to debut in October-November 2026 through its subsidiary Innovative Production Group FZ, LLC in partnership with Zimbabwe Cricket. This is a material operational and strategic initiative extending the Company's franchise-league footprint into Africa, but the disclosure is heavily caveated with execution conditions (definitive documentation, approvals, financing, venue/player availability) and explicitly states ZT20 "remains an early-stage initiative and has not yet commenced operations." The event is operational/strategic rather than fitting a specific named category, and material to investors assessing the company's growth strategy and revenue prospects.
View raw filing on EDGAR →The filing discloses results of Chicago Atlantic BDC's 2026 annual meeting of stockholders held on June 24, 2026, under Item 5.07. Two matters were voted upon: (1) re-election of two Class 2 directors (Americo Da Corte and Tracey Brophy Warson), and (2) ratification of BDO USA, P.C. as independent auditor. Vote tallies are provided for each proposal, making this a clear shareholder vote results disclosure material to investors assessing board composition and auditor selection.
View raw filing on EDGAR →The filing discloses a private placement completed on June 18, 2026, under Item 3.02 (Unregistered Sales of Equity Securities). The Company issued 15,000,000 shares of common stock to accredited investors for approximately $3,750,000 in gross proceeds, relying on Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D. This is a classic dilutive equity issuance that would materially affect investor assessment of ownership dilution and capital structure.
View raw filing on EDGAR →Ms. Tianheng Li resigned from her positions as a director and from all committee roles, including as Chair of the Compensation Committee and Chair of the Nominating and Corporate Governance Committee, effective immediately on June 23, 2026. While the filing also discloses the appointment of Chung Ming Bruce Hui to fill some of these committee chair roles, the principal disclosed action is Ms. Li's departure from the Board and her significant committee leadership positions, which is material to investors assessing board composition and governance.
View raw filing on EDGAR →Rocket One received formal notification from Nasdaq on June 24, 2026, confirming that it has regained compliance with the minimum bid price requirement of $1.00 per share under Nasdaq Listing Rule 5550(a)(2), resolving a prior delisting risk. The disclosure explicitly states "the matter is now closed," indicating resolution of a compliance deficiency that previously threatened continued listing. This is material because it directly addresses the registrant's ability to maintain its public market listing.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Ispire Technology's Annual Meeting of Stockholders held on June 23, 2026. The filing reports voting outcomes for two proposals: (1) election of five directors (Tuanfang Liu, Jiangyan Zhu, Christopher Robert Burch, Brent Cox, and John Fargis) for one-year terms, and (2) ratification of Marcum Asia LLP as the independent auditor for fiscal year ending June 30, 2026. The detailed vote tallies (votes for, against, abstained, and broker non-votes) are provided for each nominee and proposal, which is the standard format for Item 5.07 disclosures.
View raw filing on EDGAR →This Item 5.07 discloses the results of an extraordinary general meeting of RAAQ shareholders held on June 25, 2026, where shareholders voted on and approved two critical proposals: (1) the Business Combination Agreement with IQM Quantum Computers Oyj, and (2) the Merger and Plan of Merger. The voting results show overwhelming approval (13,687,335 for vs. 800,760 against on the Business Combination Proposal), representing a material M&A transaction that will result in RAAQ merging into a subsidiary of IQM. This is a classic shareholder vote result disclosure under Item 5.07, and the underlying business combination is material to investors.
View raw filing on EDGAR →Mr. Jeffrey R Geygan resigned as interim CEO of Rocky Mountain Chocolate Factory, Inc., effective June 26, 2026, as disclosed in Item 5.02. The departure of a chief executive officer is a material event affecting investor assessment of company leadership and continuity, even though he remains on the Board.
View raw filing on EDGAR →The 6-K discloses completion of a disposition of 100% equity interest in Juxing Investment Group (Hong Kong) Limited to Shengshi International Group Inc. for US$2,000,000 on June 25, 2026. This is a material asset disposition that eliminates the Company's ownership in a subsidiary and its controlled VIE entities, directly affecting the registrant's asset base and operational scope.
View raw filing on EDGAR →The filing discloses the closing of a business combination between StablecoinX Inc. and TLGY Acquisition Corp., a SPAC, pursuant to a business combination agreement dated July 21, 2025 (as amended). The press release announces the completion of this transaction, the commencement of trading on Nasdaq under ticker "USDE," and StablecoinX's resulting public status with approximately 24 million Class A shares outstanding and $275 million in ENA holdings. This is a material change of control and capital structure event.
View raw filing on EDGAR →This news release announces the completion of IsoEnergy's acquisition of Toro Energy Limited by scheme of arrangement, with Toro shareholders receiving 0.036 ISO shares per Toro share and approximately 4.36 million ISO shares issued. The transaction was approved by Toro shareholders on June 9, 2026, the Federal Court of Australia on June 15, 2026, and became effective June 16, 2026. This is a material acquisition that expands IsoEnergy's uranium development portfolio with the Wiluna Uranium Project.
View raw filing on EDGAR →This exhibit is a news release announcing the results of Cardiol Therapeutics' Annual General Meeting of Shareholders held on June 24, 2026. The disclosure reports shareholder voting outcomes on director elections (eight directors elected with vote percentages ranging from 96.24% to 99.19%) and auditor appointment (BDO Canada LLP). This is a classic shareholder_vote_results disclosure, material because it confirms the composition of the board and auditor for the ensuing fiscal year.
View raw filing on EDGAR →DEFSEC announced a registered direct offering of 673,006 common shares at CAD$3.74 per share (raising approximately CAD$2.5 million) plus concurrent unregistered warrants to purchase an additional 673,006 shares. The unregistered warrants are offered under Section 4(a)(2) and Regulation D, constituting a private placement of equity securities that will dilute existing shareholders. This is a classic dilutive issuance combining registered and unregistered equity components.
View raw filing on EDGAR →Braskem has initiated a mediation proceeding and filed for Precautionary Injunctive Relief before a bankruptcy court pursuant to Article 20-B of Brazil's bankruptcy law, explicitly stating the measures involve "financial creditors" and are designed to restructure the Company's "capital structure" in light of its "liquidity position." This signals a material financial distress event—likely triggered by covenant breaches or inability to service debt—that threatens the registrant's financial stability and requires court-supervised restructuring negotiations with creditors.
View raw filing on EDGAR →Braskem discloses ongoing negotiations with senior debt and debenture holders regarding a "possible reorganization of its capital structure" (Restructuring). The company has exchanged material proposals with investors, held in-person meetings, and is actively negotiating terms for a restructuring under an extrajudicial reorganization proceeding in Brazil. While no agreement has been reached, the disclosure of these capital structure negotiations and the company's stated commitment to finding a "consensual, structured, and orderly solution" constitutes material M&A-like activity that would affect a reasonable investor's assessment of the registrant's financial condition and future operations.
View raw filing on EDGAR →The 6-K discloses a Board of Directors resolution authorizing the divestiture of Copel's equity stake in Dona Francisca Energética S.A. (DFESA) to Gerdau S.A. under a binding offer. This constitutes a material disposition or asset sale, with the Board explicitly resolving to "proceed with the negotiation and signing of a Share Purchase Agreement for the divestment of Copel's stake in DFESA." The transaction is material to investors as it represents a significant capital allocation decision and change in the company's portfolio.
View raw filing on EDGAR →This exhibit is a news release announcing voting results from Nexa Resources' Annual General Meeting and Extraordinary General Meeting held on June 25, 2026. The document discloses shareholder votes on multiple resolutions including approval of annual accounts, board member reelections, auditor appointment, and authorized share capital amendments. The release also announces a share premium reimbursement of approximately US$0.132136 per common share (US$17.5 million total), payable August 11, 2026. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, and the capital reimbursement decision is material to investors.
View raw filing on EDGAR →The Board of Directors unanimously approved resolution PD.CA/BAK-20/2026 authorizing the institution of a mediation proceeding with financial creditors and the commencement of judicial proceedings for Emergency Precautionary Relief under Article 20-B of Brazil's Law No. 11.101/2005 (the insolvency law), as well as potential Chapter 15 ancillary proceedings in the United States. This constitutes a material bankruptcy or insolvency filing—the company is seeking protective measures and formal restructuring proceedings, which is a terminal event materially threatening the registrant's continued existence.
View raw filing on EDGAR →This exhibit discloses the voting results from Nexa Resources' Annual General Meeting and Extraordinary General Meeting of Shareholders held on June 25, 2026. The document presents tabulated vote counts for multiple resolutions including approval of annual accounts, consolidated financial statements, share premium distribution, board discharge, director reelections, board remuneration, auditor reappointment, and amendments to the Articles of Association. This is a classic shareholder_vote_results disclosure documenting the outcomes of shareholder votes at the company's annual and extraordinary meetings.
View raw filing on EDGAR →The 6-K furnishes a market notice announcing a public offering of the 9th issue of simple debentures (unsecured bonds) by AXIA Energia S.A. in an initial amount of R$ 800 million with an additional lot option of up to R$ 200 million. This is a material debt issuance under Item 2.03 equivalent, creating a direct financial obligation through the issuance of debt securities. The notice includes detailed terms, the bookbuilding procedure, and an estimated schedule for the offering.
View raw filing on EDGAR →